Optional software

Optional software
Colin Kerr
Colin Kerr
Published: Sunday, September 1, 2019
NIDEK CO., LTD., has launched the LPM optional software, a low-power mode for the YLC-500 Vixi laser photocoagulator. “LPM delivers a therapeutic effect to the retina by decreasing the laser power during photocoagulation. During treatment, the standard laser power is decreased by a specified ratio, achieving minimally invasive photocoagulation to the macular region,” said a company spokesman. According to NIDEK, notable features of this laser include an auto forward function and arcade grid scan pattern for laser delivery. “As there are no visible signs of photocoagulation during LPM treatment, these features are included to provide feedback during laser emission,” said the spokesman. www.nidek-intl.com
Tags: nidek
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...